Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC9 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPR17 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CNTF - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
TGM2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
ABCF2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CYP3A43 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
RHD - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
HRC - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CBARP - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPD1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
TP53I11 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
FBXL8 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
PCDHB1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
MIR1204 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
RRAD - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
IQSEC3 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
PTGDS - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
LOC101929240 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CYP2E1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
PAPPA2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on